Fig. 1 · Structure

Documents & Downloads

Avatrombopag

Cat. No. A14087 CAS 570406-98-3

Thrombopoietin(TPO) receptor agonist

Avatrombopag is a novel orally-active thrombopoietin (TPO) receptor agonist.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Cellular Effect

Cell Line Activity Value Description Reference
Caco-2 CC50 20.86 μM Toxicity against Caco-2 cells determined at 48 hours by intracellular ATP concentration using the CellTiter-Glo Luminescent Cell Viability Assay 10.21203/rs.3.rs-23951/v1
Caco-2 IC50 5.71 μM Determination of IC50 values for inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells after 48 hours by high content imaging 10.21203/rs.3.rs-23951/v1

Specifications

Manufacturer Adooq Bioscience
Actions Agonist
CAS Number 570406-98-3
Applications Thrombopoietin(TPO) receptor agonist
Formula C29H34Cl2N6O3S2
Molecular Weight 649.65
Synonyms AKR-501; YM477; E5501; AS 1670542
SMILES
O=C(C1CCN(C2=NC=C(C(NC3=NC(C4=CC(Cl)=CS4)=C(N5CCN(C6CCCCC6)CC5)S3)=O)C=C2Cl)CC1)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 17 mg/mL (26.16 mM)
Water Insoluble
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...